Biomarkers That Could Guide Precision Medicine Therapies for Alzheimer’s
University of Arizona Health Sciences | Apr 29, 2022
Study may provide critical insights for personalized medicine related to late-onset Alzheimer’s disease
neurodegenerative diseases
Does Multiple Sclerosis Play a Role in Cancer Screening and Diagnosis?
American Academy of Neurology | Apr 28, 2022
New study examines breast cancer and colorectal cancer detection in people with MS
Researchers Create 3-D Model for Rare Neuromuscular Disorders
National Institutes of Health | Apr 20, 2022
The organ-on-a-chip model can show how a drug could potentially treat certain diseases
Potential Clues regarding the Risk of Dementia in Women
George Institute for Global Health | Apr 06, 2022
Levels of the hormone estrogen may be linked to a woman’s risk of developing dementia in later life
Alzheimer’s Disease: The Identification of 75 Genetic Risk Factors
INSERM | Apr 05, 2022
Identifying genetic risk factors for Alzheimer's disease to improve our understanding and treatment of it
Combination of Biomarkers Can Identify Common Cognitive Disease
University of Gothenburg | Apr 04, 2022
New research has shown it is possible to identify patients with subcortical small-vessel disease
Researchers Develop New Antibody Test to Diagnose Multiple Sclerosis
Mayo Clinic | Mar 25, 2022
The study estimates a significant cost and time saving for the new test
Genetic Diversity in the Aging Human Brain
Zahraa Chorghay, PhD | Mar 18, 2022
Structural variants provide clues to cell function and disease in the brain
Multiple Sclerosis as a Case of Mistaken Identity
Zahraa Chorghay, PhD | Mar 11, 2022
Two recent studies add significant evidence toward understanding the cause of MS
Blood Test for Alzheimer’s Highly Accurate in Large, International Study
Washington University School of Medicine | Feb 23, 2022
Test is up to 93 percent accurate at identifying people at risk of Alzheimer's dementia